Literature DB >> 17218445

Role of renal sympathetic nerve activity in hypertension induced by chronic nitric oxide inhibition.

Rohit Ramchandra1, Carolyn J Barrett, Sarah-Jane Guild, Fiona McBryde, Simon C Malpas.   

Abstract

Nitric oxide levels are diminished in hypertensive patients, suggesting nitric oxide might have an important role to play in the development of hypertension. Chronic blockade of nitric oxide leads to hypertension that is sustained throughout the period of the blockade in baroreceptor-intact animals. It has been suggested that the sympathetic nervous system is involved in the chronic increase in blood pressure; however, the evidence is inconclusive. We measured renal sympathetic nerve activity and blood pressure via telemetry in rabbits over 7 days of nitric oxide blockade. Nitric oxide blockade via N(omega)-nitro-L-arginine methyl ester (L-NAME) in the drinking water (50 mg x kg(-1) x day(-1)) for 7 days caused a significant increase in arterial pressure (7 +/- 1 mmHg above control levels; P < 0.05). While the increase in blood pressure was associated with a decrease in heart rate (from 233 +/- 6 beats/min before the L-NAME to 202 +/- 6 beats/min on day 7), there was no change in renal sympathetic nerve activity (94 +/- 4 %baseline levels on day 2 and 96 +/- 5 %baseline levels on day 7 of L-NAME; baseline nerve activity levels were normalized to the maximum 2 s of nerve activity evoked by nasopharyngeal stimulation). The lack of change in renal sympathetic nerve activity during the L-NAME-induced hypertension indicates that the renal nerves do not mediate the increase in blood pressure in conscious rabbits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218445     DOI: 10.1152/ajpregu.00435.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  6 in total

Review 1.  Recording sympathetic nerve activity chronically in rats: surgery techniques, assessment of nerve activity, and quantification.

Authors:  Sean D Stocker; Martin S Muntzel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

2.  Partial neuroprotection by nNOS inhibition during profound asphyxia in preterm fetal sheep.

Authors:  Paul P Drury; Joanne O Davidson; Lotte G van den Heuij; Sidhartha Tan; Richard B Silverman; Haitao Ji; Arlin B Blood; Mhoyra Fraser; Laura Bennet; Alistair Jan Gunn
Journal:  Exp Neurol       Date:  2013-10-09       Impact factor: 5.330

3.  Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.

Authors:  Mohd Shahid; Joseph Francis; Khalid Matrougui; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-21

4.  Chronic central nervous system MC3/4R blockade attenuates hypertension induced by nitric oxide synthase inhibition but not by angiotensin II infusion.

Authors:  Alexandre A da Silva; Jussara M do Carmo; John H Dubinion; Mirian Bassi; Kasra Mokhtarpouriani; Shereen M Hamza; John E Hall
Journal:  Hypertension       Date:  2014-10-06       Impact factor: 10.190

Review 5.  Nitric oxide in the kidney : its physiological role and pathophysiological implications.

Authors:  Jongun Lee
Journal:  Electrolyte Blood Press       Date:  2008-06-30

6.  Pattern of sympathetic vasomotor activity in a model of hypertension induced by nitric oxide synthase blockade.

Authors:  Lysien I Zambrano; Roberto B Pontes; Michelle L Garcia; Erika E Nishi; Fernando N Nogueira; Elisa M S Higa; Juliana G Cespedes; Cassia T Bergamaschi; Ruy R Campos
Journal:  Physiol Rep       Date:  2019-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.